Alcobra Ltd. to Present at Investor Conferences in December
24 nov. 2014 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, Nov. 24, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Announces Third Quarter Financial Results and Provides Corporate Update
17 nov. 2014 07h00 HE
|
Alcobra Ltd.
Conference Call & Webcast at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time
TEL AVIV, Israel, Nov. 17, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical...
Alcobra Ltd. to Release Third Quarter 2014 Financial Results and Host Corporate Update Conference Call and Webcast on Monday, November 17
06 nov. 2014 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, Nov. 6, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. to Present at Investor Conferences in November
03 nov. 2014 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, Nov. 3, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Announces Presentation of New Data From Phase III Adult ADHD Study at AACAP Annual Meeting
23 oct. 2014 07h25 HE
|
Alcobra Ltd.
SAN DIEGO, Oct. 23, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive disorders,...
Alcobra Announces Topline Results From Phase III Study of MDX in Adult ADHD
06 oct. 2014 06h00 HE
|
Alcobra Ltd.
Company to hold a conference call Monday, October 6, 2014 at 8:30am EDT
TEL AVIV, Israel, Oct. 6, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company...
Alcobra Announces Completion of All Patient Visits in Phase III Clinical Trial of MDX in Adult ADHD
19 sept. 2014 16h21 HE
|
Alcobra Ltd.
TEL AVIV, Israel, Sept. 19, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. to Present at the Aegis Healthcare & Technology Conference
05 sept. 2014 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, Sept. 5, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Announces Enrollment of First Patient in Phase IIb Clinical Trial of MDX in Adolescents With ADHD
02 sept. 2014 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, Sept. 2, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Announces Enrollment of First Patient in Phase IIb Clinical Trial of MDX in Fragile X Syndrome
19 août 2014 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, Aug. 19, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company primarily focused on the development and commercialization of its proprietary drug...